Our vision is to build Hikma into a world class, leading specialty pharmaceutical company. This will be achieved through both organic and by acquisitions that align with our strategy. As we build the business, it is our goal to maintain the high standards of ethics and responsibility that have always been central to the way we operate.
- Our broad geographic footprint spans over 50 countries
- We are the largest regional pharmaceutical company in MENA
- 55.4% of our sales are generated in the MENA region
- We are the licensing partner of choice in the MENA region
- Our global injectables business serves doctors and hospitals across the US, Europe and MENA.
- We are leveraging our FDA approved facilities in the MENA region, producing products for sale in the US market
We have set out six core priorities to achieve our vision
Find out more about our senior management team
Recent acquisitions have expanded our product portfolio and widened our geographic presence